NAI INC has a total of 17 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NICOX SCIENCE IRELAND, GOLDEN BIOTECHNOLOGY CORP and AFECTA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Australia | 2 | |
#5 | Hong Kong | 2 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Yamamoto Masaichi | 13 |
#2 | Kita Kiyoshi | 11 |
#3 | Inaoka Ken Daniel | 9 |
#4 | Saimoto Hiroyuki | 7 |
#5 | Watarai Shinobu | 4 |
#6 | Nishikawa Shigeru | 3 |
#7 | Yabu Yoshisada | 2 |
#8 | Tatesawa Yu | 1 |
#9 | Tokoro Gensuke | 1 |
#10 | Honda Tsuyoshi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016093157A1 | New adjuvant | |
AU2014335301A1 | Antiparasitic agent | |
WO2013180114A1 | Agent for treating and agent for preventing dementia | |
KR20150022831A | Dihydroorotic acid dehydrogenase inhibitor | |
WO2011018858A1 | Novel mastitis vaccine |